| Gene Transfer for Patients With Sickle Cell Disease (NCT02186418) | Children's Hospital Medical Center, Cincinnati | 2014-07-01 |
| Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST (NCT02164240) | Dana-Farber Cancer Institute | 2014-07-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002) (NCT02161510) | Merck Sharp & Dohme LLC | 2014-07-01 |
| A First-In-Human Study With a Single Dose UCB7665 in Healthy Volunteers (NCT02220153) | UCB Celltech | 2014-07-01 |
| A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib (NCT02115035) | University of Arkansas | 2014-07-01 |
| DC Vaccination in CML (NCT02543749) | Charite University, Berlin, Germany | 2014-07-01 |
| A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors (NCT02210663) | AbbVie | 2014-07-01 |
| Neural Stem Cell Transplantation in Traumatic Spinal Cord Injury (NCT02326662) | Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | 2014-07-01 |
| LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel (NCT02182622) | Martin Gutierrez | 2014-07-01 |
| Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy (NCT02345772) | Western Regional Medical Center | 2014-07-01 |
| Dex as Analgesic Adjuvant in OSA Patients (NCT03613558) | Montefiore Medical Center | 2014-07-01 |
| Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma (NCT02073123) | NewLink Genetics Corporation | 2014-07-01 |
| Quantum Spectrum Radiation Emitter for Adhesive Capsulitis (NCT02133833) | Nanjing Junxie Hospital | 2014-07-01 |
| A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral (NCT02290886) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2014-07-01 |
| Phase I/II Study of KP-100IT in Acute Spinal Cord Injury (NCT02193334) | Kringle Pharma, Inc. | 2014-06-30 |
| Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma (NCT02119468) | City of Hope Medical Center | 2014-06-30 |
| Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects (NCT02145234) | Hoffmann-La Roche | 2014-06-30 |
| Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer (NCT03074032) | Avionco LLC | 2014-06-30 |
| Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) (NCT02179515) | National Cancer Institute (NCI) | 2014-06-28 |
| Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. (NCT02154776) | Novartis Pharmaceuticals | 2014-06-27 |
| A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT02162836) | Janssen Pharmaceutical K.K. | 2014-06-27 |
| Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis (NCT02335255) | Sun Pharmaceutical Industries, Inc. | 2014-06-27 |
| MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies (NCT02042989) | M.D. Anderson Cancer Center | 2014-06-27 |
| A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL (NCT02158091) | Dana-Farber Cancer Institute | 2014-06-27 |
| Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001) (NCT02132754) | Merck Sharp & Dohme LLC | 2014-06-27 |
| Safety and Efficacy of Ranibizumab for Diabetic Macular Edema (NCT01982435) | Justis Ehlers | 2014-06-24 |
| Specific PET Radioligand Binding to Translocator Protein (NCT02181582) | National Institute of Mental Health (NIMH) | 2014-06-24 |
| Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529 (NCT02164045) | ViiV Healthcare | 2014-06-24 |
| Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss (NCT02132130) | Novartis Pharmaceuticals | 2014-06-23 |
| GA-68 DOTA-TOC of Somatostatin Positive Malignancies (NCT02177773) | University of California, San Francisco | 2014-06-23 |
| Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer (NCT02168777) | Bayer | 2014-06-23 |
| A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer (NCT02146313) | Genentech, Inc. | 2014-06-22 |
| Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma (NCT02051257) | City of Hope Medical Center | 2014-06-19 |
| Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer (NCT02191761) | Biosplice Therapeutics, Inc. | 2014-06-19 |
| A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer (NCT02124148) | Eli Lilly and Company | 2014-06-18 |
| Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02159989) | National Cancer Institute (NCI) | 2014-06-18 |
| Statin Distribution (NCT02360826) | Children's Mercy Hospital Kansas City | 2014-06-17 |
| Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL) (NCT01926665) | M.D. Anderson Cancer Center | 2014-06-17 |
| PD 0332991 and Cetuximab in Patients With Incurable SCCHN (NCT02101034) | Washington University School of Medicine | 2014-06-17 |
| Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02181660) | Astellas Pharma Inc | 2014-06-16 |
| Safety Study of LY3041658 in Healthy Participants (NCT02148627) | Eli Lilly and Company | 2014-06-16 |
| Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer (NCT02167854) | Memorial Sloan Kettering Cancer Center | 2014-06-16 |
| Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis (NCT04080921) | Vinmec Research Institute of Stem Cell and Gene Technology | 2014-06-16 |
| Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma (NCT02168270) | University of Nebraska | 2014-06-16 |
| Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics (NCT02177513) | National Institute on Drug Abuse (NIDA) | 2014-06-14 |
| GEN2 Directed Cancer Immunotherapy Trial (NCT04313868) | GenVivo, Inc. | 2014-06-13 |
| S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia (NCT01925131) | SWOG Cancer Research Network | 2014-06-13 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection (NCT02185794) | Gilead Sciences | 2014-06-13 |
| PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT02049593) | Jonsson Comprehensive Cancer Center | 2014-06-12 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects (NCT02169583) | GlaxoSmithKline | 2014-06-12 |
| Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT02199665) | University of Chicago | 2014-06-12 |
| A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Kidney Disease and in Age-, Weight- and Gender-matched Healthy Participants (NCT04722484) | Bayer | 2014-06-12 |
| Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients (NCT02164006) | TG Therapeutics, Inc. | 2014-06-11 |
| Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours (NCT02145741) | Boehringer Ingelheim | 2014-06-11 |
| Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer (NCT01666756) | City of Hope Medical Center | 2014-06-11 |
| A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer (NCT02048384) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-06-10 |
| Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML) (NCT02152956) | MacroGenics | 2014-06-09 |
| Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN) (NCT02176486) | Takeda | 2014-06-09 |
| A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies (NCT02108964) | Novartis Pharmaceuticals | 2014-06-06 |
| A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer (NCT02172911) | Inovio Pharmaceuticals | 2014-06-06 |
| Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma (NCT02139397) | Giselle Sholler | 2014-06-06 |
| Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma (NCT02103335) | Celgene | 2014-06-05 |
| This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation. (NCT05015673) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2014-06-05 |
| Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida (NCT03630770) | Joseph Bliss | 2014-06-05 |
| Stem Cell Therapy to Improve Burn Wound Healing (NCT02104713) | E.Badiavas | 2014-06-04 |
| Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma (NCT02059239) | Weill Medical College of Cornell University | 2014-06-04 |
| PK Study With Pantoprazole in Obese Children and Adolescents (NCT02186652) | Phillip Brian Smith | 2014-06-04 |
| A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes (NCT02038764) | Pfizer | 2014-06-04 |
| Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy (NCT01928862) | Ferring Pharmaceuticals | 2014-06-03 |
| Taste Assessment Study of SHP429 in Healthy Adult Subjects (NCT02125292) | Shire | 2014-06-02 |
| Study of Combined Oral Contraceptive Effects in Female Subjects (NCT02157467) | ViiV Healthcare | 2014-06-02 |
| Safety Study of Efprezimod Alfa (CD24Fc, MK-7110) When Administered Intravenously in Healthy Adult Subjects (MK-7110-001) (NCT02650895) | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-06-02 |
| Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery (NCT02112162) | Washington University School of Medicine | 2014-06-01 |
| Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. (NCT02146209) | Verisfield UK Ltd. Greek Branch | 2014-06-01 |
| Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors (NCT02168725) | Traws Pharma, Inc. | 2014-06-01 |
| A Study of LY3050258 in Healthy Participants (NCT02121834) | Eli Lilly and Company | 2014-06-01 |
| Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS (NCT02048969) | Yale University | 2014-06-01 |
| Cariprazine: Comparison of Slow- and Immediate-release Forms (NCT02165098) | Gedeon Richter Plc. | 2014-06-01 |
| The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23 (NCT02097589) | University of Florida | 2014-06-01 |
| A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer (NCT02361086) | Innocrin Pharmaceutical | 2014-06-01 |
| Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial (NCT02187445) | Vanderbilt University | 2014-06-01 |
| First-in-Human Single and Multiple Dose of GLPG1690 (NCT02179502) | Lakefront Biotherapeutics NV | 2014-06-01 |
| A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers (NCT02166398) | Korea United Pharm. Inc. | 2014-06-01 |
| Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease (NCT02157714) | Prothena Biosciences Limited | 2014-06-01 |
| Drug-Drug Interaction Study in Healthy Adult Volunteers (NCT02276001) | Kowa Research Institute, Inc. | 2014-06-01 |
| 19F Hot Spot MRI of Human Adipose-derived Stem Cells for Breast Reconstruction (NCT02035085) | Johns Hopkins University | 2014-06-01 |
| Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer Patients (NCT02150135) | Seoul National University Hospital | 2014-06-01 |
| A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris (NCT02411955) | Sun Pharmaceutical Industries, Inc. | 2014-06-01 |
| Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine (NCT02178670) | Fuda Cancer Hospital, Guangzhou | 2014-06-01 |
| A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects (NCT02163278) | National Health Research Institutes, Taiwan | 2014-06-01 |
| Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women (NCT02159326) | Bayer | 2014-06-01 |
| A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension (NCT02102750) | Santen Oy | 2014-06-01 |
| Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib (NCT02155465) | Memorial Sloan Kettering Cancer Center | 2014-06-01 |
| A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel (NCT02169154) | GlaxoSmithKline | 2014-06-01 |
| UW Psilocybin Pharmacokinetics Study (NCT02163707) | University of Wisconsin, Madison | 2014-06-01 |
| Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma (NCT02166229) | Yale University | 2014-06-01 |
| Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block (NCT02466347) | Intech Biopharm Ltd. | 2014-06-01 |
| Pazopanib Tolerability When Given With Food (NCT02138526) | Radboud University Medical Center | 2014-06-01 |
| A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects (NCT02169934) | Trevena Inc. | 2014-06-01 |
| Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine (NCT02131545) | Mayo Clinic | 2014-06-01 |